F894-2007 Screening compound: 1-{[5-(5-cyclobutyl-1,2,4-oxadiazol-3-yl)-2-methylthiophen-3-yl]sulfonyl}-N-(2,3-dimethylphenyl)piperidine-3-carboxamide

F894-2007 Screening compound: 1-{[5-(5-cyclobutyl-1,2,4-oxadiazol-3-yl)-2-methylthiophen-3-yl]sulfonyl}-N-(2,3-dimethylphenyl)piperidine-3-carboxamide
F894-2007 Screening compound: 1-{[5-(5-cyclobutyl-1,2,4-oxadiazol-3-yl)-2-methylthiophen-3-yl]sulfonyl}-N-(2,3-dimethylphenyl)piperidine-3-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound F894-2007
1-{[5-(5-cyclobutyl-1,2,4-oxadiazol-3-yl)-2-methylthiophen-3-yl]sulfonyl}-N-(2,3-dimethylphenyl)piperidine-3-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

F894-2007

Molecular Formula

C25H30N4O4S2 (C25 H30 N4 O4 S2)

Compound Name

1-{[5-(5-cyclobutyl-1,2,4-oxadiazol-3-yl)-2-methylthiophen-3-yl]sulfonyl}-N-(2,3-dimethylphenyl)piperidine-3-carboxamide

IUPAC name

1-{[5-(5-cyclobutyl-124-oxadiazol-3-yl)-2-methylthiophen-3-yl]sulfonyl}-N-(23-dimethylphenyl)piperidine-3-carboxamide

SMILES

Cc(sc(-c1noc(C2CCC2)n1)c1)c1S(N(CCC1)CC1C(Nc1c(C)c(C)ccc1)=O)(=O)=O

InChI

InChI=1S/C25H30N4O4S2/c1-15-7-4-11-20(16(15)2)26-24(30)19-10-6-12-29(14-19)35(31,32)22-13-21(34-17(22)3)23-27-25(33-28-23)18-8-5-9-18/h4,7,11,13,18-19H,5-6,8-10,12,14H2,1-3H3,(H,26,30)/t19-/m0/s1

InChI Key

CTJYXMPQSXXEPA-IBGZPJMESA-N

MDL Number (MFCD)

MFCD27202645

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

514.67

Hydrogen Bond Acceptors Count

10.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

5.035

Distribution Coefficient, logD

5.035

Water Solubility, LogSw

-4.62

Polar Surface Area

87.224

Acid Dissociation Constant (pKa)

11.40

Base Dissociation Constant (pKb)

-0.30

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

48.00

F894-2007 in Drug Discovery

Included in Screening Libraries

MCL1 Targeted Library (12200 compounds)

PPI Inhibitors Tripeptide Mimetics (23972 compounds)

Protein Arginine Methyltransferases Library (27925 compounds)

Histone Deacetylases (HDAC) Targeted Library (9760 compounds)

Peptidomimetic Library (37031 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Metabolic
  • Cancer
  • Nervous system
  • Hemic and lymphatic
  • Endocrine
  • Immune system
Mechanism of action:
  • PPI modulators
  • Epigenetic
  • Epigenetic
  • PPI modulators
Structure:
  • Mimetics
  • Mimetics
Targets:
  • Others

References: we are preparing a list of scientific research reports with F894-2007 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound F894-2007?
Check Price and Availability of F894-2007, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of F894-2007 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for F894-2007
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for F894-2007
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of F894-2007 available by request